Latest debt-to-equity ratio
Virax Biolabs Group Debt-to-equity ratio
Direct answer
Virax Biolabs Group's debt-to-equity ratio is 5.65%.
The verified market snapshot reports 5.65%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 9, 2026.
Get free Virax Biolabs Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 5.65%
Explore related company data
View Virax Biolabs Group's market capitalizationView Virax Biolabs Group's price-to-book ratioView Virax Biolabs Group's return on equityView Virax Biolabs Group's dividend yieldView Virax Biolabs Group's 52-week price rangeView Virax Biolabs Group's revenue growthView Virax Biolabs Group's profit marginView all Virax Biolabs Group key metricsReturn to Virax Biolabs Group profile